logo

Ptc Therapeutics Inc. (PTCT)



Trade PTCT now with
  Date
  Headline
8/17/2020 8:11:05 AM PTC : EU Accepts Marketing Authorization Application For Evrysdi For Treatment Of Spinal Muscular Atrophy
7/20/2020 7:35:49 AM PTC Therapeutics Announces Deal To Monetize Portion Of Risdiplam Royalty Stream For $650 Mln From Royalty Pharma
7/8/2020 8:15:34 AM PTC Therapeutics Reports First Patient Dosed In Phase 1 Trial For PTC857
6/29/2020 8:23:06 AM PTC Therapeutics Announces CHMP Recommendation Of Translarna Label Update For Non-Ambulatory Patients With DMD
6/17/2020 6:31:45 AM PTC Therapeutics Begins Phase 2/3 Clinical Trial To Evaluate PTC299 For COVID-19
6/1/2020 8:01:35 AM PTC Therapeutics Completes Acquisition Of Censa Pharmaceuticals
4/28/2020 1:15:26 AM PTC Therapeutics Reports Positive Results From Part 2 Of The Pivotal FIREFISH Study Evaluating Risdiplam
4/17/2020 8:04:33 AM PTC Therapeutics Names Matthew Klein Chief Development Officer And Eric Pauwels To Chief Business Officer
3/16/2020 8:19:05 AM PTC Therapeutics COO Marcio Souza Resigns
3/2/2020 4:03:22 PM PTC Therapeutics Q4 Loss/share $1.37 Vs. Loss $0.96 Year Ago
2/6/2020 5:03:13 AM PTC Therapeutics Presents Positive 1 Year Clinical Data From Part 2 Of The Pivotal SUNFISH Study Of Risdiplam
2/3/2020 8:10:46 AM PTC Data Shows Translarnaä Preserves Ability To Walk For Longer In Children With Duchenne Muscular Dystrophy
1/23/2020 1:03:07 AM PTC Therapeutics Says FIREFISH Study Meets Primary Endpoint In Patients Living With Type 1 SMA
11/25/2019 1:32:18 AM PTC Therapeutics: FDA Granted Priority Review For NDA For Risdiplam For Spinal Muscular Atrophy Treatment